×

IN SUBGROUP OF HIGHEST-RISK PATIENTS ALL-CAUSE DEATH RISK REDUCED BY 29 PCT FOR PRALUENT VS PLACEBO - RESEARCHERS

IN SUBGROUP OF HIGHEST-RISK PATIENTS ALL-CAUSE DEATH RISK REDUCED